Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the polyp prevention trial

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 6, 2010, Pages 1441-1452

  Bobe, Gerd ^a   Murphy, Gwen ^a   Rogers, Connie J ^a   Hance, Kenneth W ^a   Albert, Paul S ^b   Laiyemo, Adeyinka O ^a   Sansbury, Leah B ^a   Lanza, Elaine ^a   Schatzkin, Arthur ^a   Cross, Amanda J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C PEPTIDE; FLAVONOL; HOMOCYSTEINE; LEPTIN;

ADULT; AGED; ARTICLE; BEAN; CANCER RECURRENCE; COLORECTAL ADENOMA; CONTROLLED STUDY; DIET; FAT INTAKE; FEMALE; FIBER; FOOD INTAKE; FRUIT; HIGH FIBER DIET; HUMAN; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; POLYP; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VEGETABLE; ADENOMA; BLOOD; COLORECTAL NEOPLASMS; FOLLOW UP; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; RISK FACTOR; TUMOR RECURRENCE; VERY ELDERLY;

ADENOMA; ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; C-PEPTIDE; COLORECTAL NEOPLASMS; DIET; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; LEPTIN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECURRENCE; RISK FACTORS;

EID: 77953296329     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-1082     Document Type: Article

References (59)

1. Giovannucci E, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control 1996;7:253-63.
2. IARC. Weight control and physical activity. Vol. 6. Lyon (France): IARC Press; 2002.
3. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity and the prevention of cancer: a global perspective. Washington (DC): AICR; 2007.
4. Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer 2006;94:1221-5.
5. Housa D, Housova J, Vernerova Z, Haluzik M. Adipocytokines and cancer. Physiol Res 2006;55:233-44.
6. Hursting SD, Lashinger LM, Wheatley KW, et al. Reducing the weight of cancer: mechanistic targets for breaking the obesitycarcinogenesis link. Best Pract Res Clin Endocrinol Metab 2008;22:659-69.
7. Gunter MJ, Leitzmann MF. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem 2006;17:145-56.
8. Kumor A, Daniel P, Pietruczuk M, Malecka-Panas E. Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis 2009;24:275-81.
9. Otake S, Takeda H, Suzuki Y, et al. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res 2005;11:3642-6.
10. Erarslan E, Turkay C, Koktener A, Koca C, Uz B, Bavbek N. Association of visceral fat accumulation and adiponectin levels with colorectal neoplasia. Dig Dis Sci 2009;54:862-8.
11. Ferroni P, Palmirotta R, Spila A, et al. Prognostic significance of adiponectin levels in non-metastatic colorectal cancer. Anticancer Res 2007;27:483-9.
12. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005;97:1688-94.
13. Fukumoto J, Otake T, Tajima O, et al. Adiponectin and colorectal adenomas: Self Defense Forces Health Study. Cancer Sci 2008;99:781-6.
14. Lukanova A, Soderberg S, Kaaks R, Jellum E, Stattin P. Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2006;15:401-2.
15. Chia VM, Newcomb PA, Lampe JW, et al. Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2007;16:2697-703.
16. Tamakoshi K, Toyoshima H, Wakai K, et al. Leptin is associated with an increased female colorectal cancer risk: a nested casecontrol study in Japan. Oncology 2005;68:454-61.
17. Stattin P, Lukanova A, Biessy C, et al. Obesity and colon cancer: does leptin provide a link? Int J Cancer 2004;109:149-52.
18. Stattin P, Palmqvist R, Soderberg S, et al. Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden. Oncol Rep 2003;10:2015-21.
19. Wallace AM, Sattar N, McMillan DC. Effect of weight loss and the inflammatory response on leptin concentrations in gastrointestinal cancer patients. Clin Cancer Res 1998;4:2977-9.
20. Bolukbas FF, Kilic H, Bolukbas C, et al. Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC Cancer 2004;4:29.
21. Arpaci F, Yilmaz MI, Ozet A, et al. Low serum leptin level in colon cancer patients without significant weight loss. Tumori 2002;88:147-9.
22. Hovorka R, Jones RH. How to measure insulin secretion. Diabetes Metab Rev 1994;10:91-117.
23. Kaaks R, Toniolo P, Akhmedkhanov A, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000;92:1592-600.
24. Ma J, Giovannucci E, Pollak M, et al. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 2004;96:546-53.
25. Jenab M, Riboli E, Cleveland RJ, et al. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2007;121:368-76.
26. Wei EK, Ma J, Pollak MN, et al. C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women. Cancer Epidemiol Biomarkers Prev 2006;15:750-5.
27. Tsilidis KK, Brancati FL, Pollak MN, et al. Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control 21:1-10.
28. Kaczka A, Kumor A, Pietruczuk M, Malecka-Panas E. Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer. Pol Merkur Lekarski 2007;22:373-5.
29. Meigs JB, Jacques PF, Selhub J, et al. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 2001;24:1403-10.
30. Lucock MD. Synergy of genes and nutrients: the case of homocysteine. Curr Opin Clin Nutr Metab Care 2006;9:748-56.
31. Zhou J, Austin RC. Contributions of hyperhomocysteinemia to atherosclerosis: causal relationship and potential mechanisms. Biofactors 2009;35:120-9.
32. Powers HJ, Hill MH, Welfare M, et al. Responses of biomarkers of folate and riboflavin status to folate and riboflavin supplementation in healthy and colorectal polyp patients (the FAB2 Study). Cancer Epidemiol Biomarkers Prev 2007;16:2128-35.
33. Martinez ME, Giovannucci E, Jiang R, et al. Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence. Int J Cancer 2006;119:1440-6.
34. Hwang NC, Kim YH, Shim SG, et al. Is serum homocysteine level elevated in colorectal tumor? Korean J Gastroenterol 2005;45:97-102.
35. Al-Ghnaniem R, Peters J, Foresti R, Heaton N, Pufulete M. Methylation of estrogen receptor á and mutL homolog 1 in normal colonic mucosa: association with folate and vitamin B-12 status in subjects with and without colorectal neoplasia. Am J Clin Nutr 2007;86:1064-72.
36. Ashktorab H, Begum R, Akhgar A, et al. Folate status and risk of colorectal polyps in African Americans. Dig Dis Sci 2007;52:1462-70.
37. Lanza E, Hartman TJ, Albert PS, et al. High dry bean intake and reduced risk of advanced colorectal adenoma recurrence among participants in the Polyp Prevention Trial. J Nutr 2006;136:1896-903.
38. Bobe G, Sansbury LB, Albert PS, et al. Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev 2008;17:1344-53.
39. Sansbury LB, Wanke K, Albert PS, Kahle L, Schatzkin A, Lanza E. The effect of strict adherence to a high-fiber, high-fruit and -vegetable, and low-fat eating pattern on adenoma recurrence. Am J Epidemiol 2009;170:576-84.
40. Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med 2000;342:1149-55.
41. Lanza E, Schatzkin A, Daston C, et al. Implementation of a 4-y, high-fiber, high-fruit-and-vegetable, low-fat dietary intervention: results of dietary changes in the Polyp Prevention Trial. Am J Clin Nutr 2001;74:387-401. (Pubitemid 32802026)
42. U.S. Department of Agriculture. USDA database for the flavonoid content of selected foods. c2007 [cited 2010 April 7]. Available from: http://www.nal.usda.gov/fnic/foodcomp/Data/Flav/Flav02.pdf 2007.
43. Caan BJ, Lanza E, Schatzkin A, et al. Does nutritionist review of a self-administered food frequency questionnaire improve data quality? Public Health Nutr 1999;2:565-9.
44. Kim YI, Fawaz K, Knox T, et al. Colonic mucosal concentrations of folate correlate well with blood measurements of folate status in persons with colorectal polyps. Am J Clin Nutr 1998;68:866-72.
45. Murphy G, Sansbury LB, Cross AJ, et al. Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial. Cancer Causes Control 2008;19:751-8.
46. Martinez ME, Henning SM, Alberts DS. Folate and colorectal neoplasia: relation between plasma and dietary markers of folate and adenoma recurrence. Am J Clin Nutr 2004;79:691-7.
47. van den Donk M, Pellis L, Crott JW, et al. Folic acid and vitamin B-12 supplementation does not favorably influence uracil incorporation and promoter methylation in rectal mucosa DNA of subjects with previous colorectal adenomas. J Nutr 2007;137:2114-20.
48. Hazra A, Selhub J, Chao WH, Ueland PM, Hunter DJ, Baron JA. Uracil misincorporation into DNA and folic acid supplementation. Am J Clin Nutr 91:160-5.
49. Aparicio T, Guilmeau S, Goiot H, et al. Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat colonic mucosa. Gastroenterology 2004;126:499-510. (Pubitemid 38182307)
50. Aparicio T, Kotelevets L, Tsocas A, et al. Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in Apc(Min/+) mice. Gut 2005;54:1136-45.
51. FitzGerald AJ, Mandir N, Goodlad RA. Leptin, cell proliferation and crypt fission in the gastrointestinal tract of intravenously fed rats. Cell Prolif 2005;38:25-33. (Pubitemid 40229265)
52. Koda M, Sulkowska M, Kanczuga-Koda L, Surmacz E, Sulkowski S. Overexpression of the obesity hormone leptin in human colorectal cancer. J Clin Pathol 2007;60:902-6.
53. Aloulou N, Bastuji-Garin S, Le Gouvello S, et al. Involvement of the leptin receptor in the immune response in intestinal cancer. Cancer Res 2008;68:9413-22.
54. Paik SS, Jang SM, Jang KS, Lee KH, Choi D, Jang SJ. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma. Ann Surg Oncol 2009;16:297-303.
55. Uddin S, Bavi PP, Hussain AR, et al. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication. Carcinogenesis 2009;30:1832-40.
56. Yoneda K, Tomimoto A, Endo H, et al. Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue. Oncol Rep 2008;20:479-83.
57. Fenton JI, Birmingham JM, Hursting SD, Hord NG. Adiponectin blocks multiple signaling cascades associated with leptin-induced cell proliferation in Apc Min/+ colon epithelial cells. Int J Cancer 2008;122:2437-45.
58. Fujisawa T, Endo H, Tomimoto A, et al. Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut 2008;57:1531-8.
59. Ealey KN, Archer MC. Elevated circulating adiponectin and elevated insulin sensitivity in adiponectin transgenic mice are not associated with reduced susceptibility to colon carcinogenesis. Int J Cancer 2009;124:2226-30.